Tolaney, S. M., Bianchini, G., Borges, V. F., Ciruelos, E. M., Im, S., Janni, W., Jhaveri, K. L., Schmid, P., Werutsky, G., Luan, Y., Park, E., Vecchio, D., Pistilli, B. (2026). OPERA-02: A phase 3 study of palazestrant plus ribociclib as first-line treatment of ER+, HER2- advanced breast cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps1152